Cinepazide

CHEMBL1874750 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
417.5 g/mol
LogP
1.5
Phase
4

A piperazine derivative with vasodilatory properties, used in some countries for the treatment of cerebrovascular and peripheral vascular disorders. Its mechanism involves inhibition of cyclic AMP phosphodiesterase and calcium channel antagonism. It is not approved in the United States or most major Western markets.

Molecular Weight

417.5000 g/mol

LogP

1.50

TPSA

71.60 Ų

Lipinski RO5

Pass

Therapeutic Areas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1cc(/C=C/C(=O)N2CCN(CC(=O)N3CCCC3)CC2)cc(OC)c1OC

InChI

InChI=1S/C22H31N3O5/c1-28-18-14-17(15-19(29-2)22(18)30-3)6-7-20(26)25-12-10-23(11-13-25)16-21(27)24-8-4-5-9-24/h6-7,14-15H,4-5,8-13,16H2,1-3H3/b7-6+

Molecular Formula

C22H31N3O5

HBD / HBA

- / 6

Rotatable Bonds

7

Heavy Atoms

30

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

A piperazine derivative with vasodilatory properties, used in some countries for the treatment of cerebrovascular and peripheral vascular disorders. Its mechanism involves inhibition of cyclic AMP phosphodiesterase and calcium channel antagonism. It is not approved in the United States or most major Western markets.

Yes, Cinepazide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1874750. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5282459. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.